Investors in Sarepta Therapeutics, Inc. (NASDAQ:SRPT) had a good week, as its shares rose 3.3% to close at US$87.11 following the release of its yearly results. The statutory results were mixed ...

Sarepta Therapeutics (NASDAQ:SRPT) soared in trading after the company announced that the U.S. Food and Drug Administration (FDA) had granted accelerated expansion to the labeled indication for ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) insiders who purchased shares in the last 12 months were richly rewarded last week. The stock climbed by 5.3% resulting in a US$375m addition to the ...

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the August 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the July 3rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

Fintel reports that on May 14, 2024, Oppenheimer upgraded their outlook for Sarepta Therapeutics (NasdaqGS:SRPT) from Perform to Outperform. Analyst Price Forecast Suggests 29.21% Upside As of May ...

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the June 2024 expiration. One of the key data points that goes into the price an option buyer is ...

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the April 4th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options begin trading this week, for the June 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options begin trading today, for the January 2022 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...

But on the other hand it also has US$1.74b in cash, leading to a US$646.7m net cash position. NasdaqGS:SRPT Debt to Equity History July 12th 2021 A Look At Sarepta Therapeutics' Liabilities ...

Stocks with the "Perfect 10" Smart Score on TipRanks have the potential to beat the market. It’s worth noting that stocks with this top score have historically surpassed the S&P 500 Index (SPX ...